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Hyaluronidase is an enzyme that has temporary and reversible enzymatic effects on the matrix of connective 
tissue. When added to local anesthetics in pain treatments, it enhances their infiltration and dispersal into 
tissues. It is widely used in anesthesia for ocular , dental, and plastic surgery . Reports of drug hypersensitivity 
to hyaluronidase are rare and are usually confined to peribulbar or retrobulbar anesthesia during ophthalmic 
surgery. However, few reports exist on adverse drug reaction after epidural injection. We have observed two 
patients experiencing anaphylactic shock caused by hyaluronidase following epidural injection. Most of the 
patients with a hypersensitivity to hyaluronidase had one previous uneventful injection containing 
hyaluronidase, implying that sensitization had taken place. However, hypersensitivity occurring at the first 
administration is possible. A positive skin test can help establish the diagnosis. Although rare, the possibility 
of an allergic reaction to hyaluronidase should be considered even in patients with no known previous exposure. 
(Korean  J  Pain  2011;  24:  221-225)
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    Hyaluronidase is an enzyme that hydrolyzes the gluco-
saminic  bond  between  hyaluronic  acid,  an  intercellular 
substance, and connective tissue. It also increases pene-
tration of interstitial drugs [1,2]. Thus, hyaluronidase is often 
used as an additive agent in many clinical areas, such as 
pain treatment, to improve the diffusion of drugs [3,4]. It 
is also mixed with local anesthetics in pain treatment to 
produce  an  enhanced  anti-inflammatory  and  prolonged 
analgesic effect [5]. 
    Although hyaluronidase has been in use for a long 
time, few reports exist on allergic reactions to it. Moreover, 
of those that exist, most concern allergic reactions that 
occur around the eyeballs following ophthalmic anesthesia 
(peibulbar or retrobulbar block) [2,6]. Recently, allergic re-
actions accompanying pain treatment have been reported 
a s  h y a l u r o n i d a s e  h a s  b e g u n  t o  b e  m i x e d  w i t h  l o c a l  
anesthetics.  However,  anaphylactic  shock  following  epi-
dural injection is rarely reported [7].
    W e report here on cases of anaphylactic shock that 
occurred after the use of hyaluronidase during epidural block.222 Korean J Pain Vol. 24, No. 4, 2011
Fig. 1. Fluoroscopic image of left L5 transforaminal epidural
injection. There is no vascular uptake.
Fig. 2. This figure shows the generalized skin rash and 
urticaria of patient’s body.
CASE  REPORT
1. Case 1
    A 46-year old, female patient visited our clinic with 
the main complaints of back pain and numbness at the left 
lower limb, which had begun six months earlier. The pa-
tient stated that the pain had become severe since she had 
undergone discectomy at L4/5 for the back pain in April, 
2010, which was one month before visiting our clinic. In 
the  physical  examination,  the  result  of  the  straight  leg 
raising test was 90
o/60
o and that of the Patrick test was 
n e g a t i v e .  N u m b n e s s  w a s  f o u n d  a l o n g  t h e  p o s t e r o l a t e r a l 
aspect of the left lower limb, but t no weakening of muscu-
lar strength was observed. Tender points were present on 
the left gluteus medius and piriformis. The patient had no 
history of allergic reaction to any drugs, foods, or pollen. 
The MRI finding was “L4/5 bulging disc with annular tear, 
decompressed state and L5/S1 bulging disc.” Under the di-
agnosis of post-laminectomy syndrome, a transforaminal 
epidural block was performed at the left L5 with 0.18% lev-
obupivacaine 3 ml, triamcinolone 20 mg, and hyaluronidase 
1,500 IU (Fig. 1). The procedure was performed under re-
al-time fluoroscopic guidance, and the drugs were injected 
after  insuring  that  there  was  no  vascular  uptake.  The 
postoperative vital signs of the patient were stable with no 
allergic symptoms, such as skin rash. Since the back pain 
and the numbness at the left lower limb became severe 
again three months later, the procedure was repeated in 
the  same  manner  with  the  same  drugs  and  dosages. 
Immediately after the epidural injection, nausea, skin flare, 
generalized urticaria, respiratory distress, and hypotension 
(70/30 mmHg) occurred in the patient (Fig. 2). The symp-
toms  were  relieved  after  immediately  injecting  Ringer’s 
lactate solution and performing an intravenous injection of 
ephedrine 5 mg, dexamethasone 5 mg, and chlorphenir-
amine maleate 4 mg. 
    Among the skin allergy tests, the skin prick test 
showed a negative finding for hyaluronidase and the con-
trast media, while the intradermal test showed a positive 
finding to hyaluronidase 15 IU/ml (1：100) with a wheal and 
flare at 8 mm. The intradermal test also showed a negative 
finding for the contrast media. The blood test showed that 
the total Ig E level was 86 IU/ml (0-183 IU/ml), which was 
normal.
2. Case 2 
    A 35-year old, male patient visited our clinic with the 
main complaints of back pain and numbness in the right 
lower limb that had begun three years earlier. The patient 
h a d  n o  h i s t o r y  o f  a l l e r g i c  r e a c t i o n  o r  o t h e r  s p e c i f i c  
findings. The patient had never undergone a nerve block 
that included hyaluronidase. However, the patient had had 
several bee venom injections as a form of treatment at an 
oriental medical clinic. We performed caudal epidural in-
jection with 0.18% levobupivacaine 8 ml, triamcinolone 20 
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Fig. 3. Fluoroscopic image 
of caudal epidural block. 
There is no vascular uptake.
was performed under real-time fluoroscopic guidance. The 
drugs were injected after insuring that there was no vas-
cular uptake. Immediately after the epidural injection, the 
patient experienced nausea and vomiting, skin flare, gen-
eral urticaria, and hypotension (75/35 mmHg). The symp-
toms diminished immediately after injecting Ringer’s lac-
tate solution and giving an intravenous injection of ephe-
drine 5 mg, dexamethasone 5 mg, and chlorpheniramine 
maleate 4 mg. 
    Among the skin allergy tests, the skin prick test 
showed positive findings with a wheal and flare of 10 mm 
and 4 mm in diameters to hyaluronidase 1,500 IU/ml (1：1) 
and 150 IU/ml (1：10), respectively. Both the prick test and 
intradermal test showed a negative finding to the contrast 
media. The blood test showed that the total IgE level was 
213 IU/ml (0-183 IU/ml), which is an elevated value.
DISCUSSION
    Hyaluronidase is a synechotomic agent that decreases 
fibrosis and chronic inflammation that occurs after spinal 
surgery. Hyaluronidase is mixed with local anesthetics for 
pain treatment [8]. Schulze et al. [9] reported that hyalur-
onidase mixed with local anesthetics is effective for use as 
a local anesthesia because the activity of hyaluronidase is 
not decreased and, clinically, it reduces anesthetic dose 
and facilitate diffusion of local anesthetics.
    F ew reports exist concerning allergic reactions to 
hyaluronidase. The actual incidence is difficult to assess 
because weak allergic reactions are often recovered from 
spontaneously and, thus, may not be recognized. In most 
o f  t h e  c a s e s ,  a l l e r g i c  r e a c t i o n s  t o  h y a l u r o n i d a s e  o c c u r  
when re-exposure to hyaluronidase is sensitized after pre-
vious exposure to it without any specific problems [10,11]. 
However, an allergic reaction to hyaluronidase may occur 
on the first exposure, even though this is rare [12]. In the 
first case reported here, the patient was sensitized to hya-
luronidase after it was injected into the first epidural space. 
The second exposure caused an anaphylactic shock. The 
patient reported on in the second case had never under-
gone a nerve block that included hyaluronidase. However, 
this patient experienced anaphylactic shock after the first 
injection. The patient might have been exposed to hyalur-
onidase in bee venom, since he had undergone bee venom 
i n j e c t i o n  a t  a n  o r i e n t a l  m e d i c a l  c l i n i c .  T h e  s e n s i t i z a t i o n 
might have caused the anaphylactic shock. The venom of 
bees, red ants, scorpions, and hornets contains various 
p r o t e i n  a l l e r g e n s ,  i n c l u d i n g  h y a l u r o n i d a s e ,  a s  ' s p r e a d i n g 
factors' which help spread the principal components of the 
venom. The hyaluronidases of the venom of these insects 
share similar sequence identities and structures [13].
    The start of the allergic reaction may be acute, when 
it  occurs  during  an  operation  after  anesthesia,  inter-
mediate, when it occurs within a few hours, or delayed, 
when it occurs a few days or weeks later [10]. The main 
clinical symptoms of allergic reaction, following the use of 
anesthesia that contains hyaluronidase around the eyeballs 
during ophthalmic surgery, are local symptoms, such as 
edema around the eyeballs, flare, itching, pain, exopthal-
mosis, and limited motion of the extraocular muscle. The 
clinical symptoms of the two patients reported here oc-
curred immediately after the injection of hyaluronidase. In 
these  cases,  anaphylactic  shock  accompanied  general 
symptoms such as nausea and vomiting, general urticaria, 224 Korean J Pain Vol. 24, No. 4, 2011
and hypotension.
    The type of allergic reaction caused by hyaluronidase 
has not been definitely identified. In many reported cases, 
the allergic reactions occurred during a second operation 
that was carried out after a patient had previously under-
gone injection of local anesthetics that included hyalur-
onidase, often in ophthalmic surgeries, such as a cataract 
surgery [12,14,15]. Skin allergy tests are important for the 
diagnosis and treatment of an allergy to hyaluronidase. An 
intradermal test is performed when the result of a prick 
test is not definite. A prick test gives a positive judgment 
if the wheal is greater than 4 mm, and the test is highly 
specific. An intradermal test gives a positive result if the 
wheal is greater than 8 mm. Such a test is highly sensitive. 
The intradermal test and prick test are commonly used to 
determine Type I (IgE mediated type and acute type) and 
Type IV (T-cell mediated type and delayed type) hyper-
sensitive reactions [11,16]. Given that the allergic symptoms 
that appeared followed an exposure to hyaluronidase and 
given the results of the skin allergy tests, the allergic re-
actions to hyaluronidase may be considered Type I or Type 
I V  h y p e r s e n s i t i v e  r e a c t i o n s .  F o r  t h e  p a t i e n t  i n  t h e  f i r s t 
case, the prick test showed a negative result with respect 
to hyaluronidase and the contrast media. Thus, an intra-
dermal test, which is more sensitive, was performed, which 
resulted in the positive response to the 1：100 diluted hya-
luronidase of an 8 mm wheal. For the patient in the second 
case, the prick test showed positive reactions to hyalur-
onidase diluted at the ratios of 1：1 and 1：10, which ap-
pear ed as w h ea ls gr eater than 4 mm at tw o positions. 
Since the allergic reactions displayed by the patients in our 
cases  occurred  immediately  after  exposure  to  hyalur-
onidase and the subsequent skin allergy tests showed pos-
itive findings, the reactions are assumed to be Type I 
hypersensitive allergic reactions.
    In many previous reports, hyaluronidase was either 
injected mixed with local anesthetics for ophthalmic sur-
geries, such as a cataract surgery, or it was intravenously 
injected as an additive during anticancer therapy [17,18]. 
The initial signs of allergic reactions are dependent on the 
injection pathways. Local angioedema or urticaria occurs 
if  h y a l u r o n i d a se  i s in j ec t ed  w i t h l o c a l a n e s t h e t i c s,  w h i l e 
anaphylactic shock, general urticaria, or respiratory dis-
tress occur in most patients if it is injected intravenously. 
The clinical symptoms of the allergic reactions are reduced 
within a few minutes using steroid treatment. Additional 
administration of an antihistamine improves the treatment 
and reduces the side effects of high steroid doses. In our 
cases, hyaluronidase was injected into the epidural space 
with local anesthetics for pain treatment. This caused a 
general anaphylactic shock which included severe hypo-
tension. The symptoms were improved by using a steroid 
and an antihistamine as well as by injecting fluid and a 
pressor agent.
    In conclusion, although allergic reactions to hy aluroni-
dase are rare, the use of hyaluronidase should be avoided 
if a patient has a history of allergic reaction to hyalur-
onidase or if a skin allergy test shows a positive finding. 
Even though the clinical symptoms are weak and are often 
recovered from spontaneously, an anaphylactic reaction, 
which is accompanied by severe hypotension, may occur. 
An  allergic  reaction  may  occur  upon  the  first  admin-
istration of hyaluronidase even when a patient has had no 
known previous exposure.
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